Company: KAVL
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001731122-25-001141
Chunk: 8

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 8
---
 this role prior to the closing of the Merger Agreement.
Pursuant to the terms of the Merger Agreement, the outside date for the closing the transactions contemplated by the Merger Agreement
is February 15, 2025 and therefore under the Merger Agreement, the parties thereto have specified rights to terminate the Merger Agreement.
No assurances can be made that the transactions contemplated by the Merger Agreement will ever close. The transactions contemplated by
the Merger Agreement are described in further detail in our Current Report on Form 8-K filed with the SEC on September 27, 2024 ,
which is incorporated by reference into our Annual Report on Form 10-K, filed with the SEC on February 10, 2025, which is incorporated
by reference in to this prospectus. Although the outside date of the Merger Agreement has occurred, the Company and Delta continue to
negotiate a closing of the transaction, however, there are no assurances that a closing of the transactions contemplated by the Merger
Agreement will ever occur.

<div align='center'>3</div>

Recent Dev elopments

Nasdaq Compliance

On April 3, 2025, we received a letter from Nasdaq notifying us that we were no longer in compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(a)(2) (the “ Bid Price Rule”). Although Nasdaq has granted us 180 calendar days, or until September 30, 2025, to regain compliance with the Bid Price Rule, there can be no assurance that we will regain such compliance and Nasdaq could make a determination to delist our common stock.

Any delisting determination by Nasdaq could seriously decrease or eliminate the value of an investment in our common stock and other securities linked to our common stock

Stockholder Approval of Potential Reverse Split of our Common Stock

On February 21, 2025, the Board of Directors of the Company unanimously authorized and approved a reverse split of the issued and outstanding shares of the Company’s common stock at a ratio of any whole number within the range between one-for-two (1:2) and one-for-twenty (1:20), with such ratio to be determined in the discretion of the Registrant’s Board of Directors and with such action to be effected at such time and date as determined by the Board of Directors (the “Reverse Split”).

The Reverse Split was also authorized and approved by the Action by Written